Back
Blackrock Enhanced Cap&Inc Fund, Vs. Neurogene Industry Stock Comparison
Buy
65
CII
Blackrock Enhanced Cap&Inc Fund,
Last Price:
19.61
Seasonality Move:
2.06%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Buy
65
Blackrock Enhanced Cap&Inc Fund, (CII)
is a Buy
Is Blackrock Enhanced Cap&Inc Fund, a Buy, Sell or Hold?
- The current Blackrock Enhanced Cap&Inc Fund, [CII] share price is $19.59. The Score for CII is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CII is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CII Stock Price Chart
What is Blackrock Enhanced Cap&Inc Fund,'s stock price today?
-
The Blackrock Enhanced Cap&Inc Fund, share price today is $19.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CII is experiencing slight selling pressure.
CII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 46.39 | Sell |
| Chaikin Money Flow: | -32799 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.52 - 19.92) | Sell |
| Bollinger Bands (100): | (19.11 - 19.89) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 35.74 | Sell |
| Chaikin Money Flow: | -452975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.4 - 61.5) | Sell |
| Bollinger Bands (100): | (34.32 - 50.52) | Sell |
CII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.86 | Sell |
| 20-day SMA: | 19.69 | Sell |
| 50-day SMA: | 19.59 | Buy |
| 200-day SMA: | 19.39 | Buy |
| 8-day EMA: | 19.77 | Sell |
| 20-day EMA: | 19.72 | Sell |
| 50-day EMA: | 19.61 | Sell |
| 200-day EMA: | 19.32 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Sell |
| 20-day SMA: | 51.47 | Sell |
| 50-day SMA: | 46.76 | Sell |
| 200-day SMA: | 38.99 | Sell |
| 8-day EMA: | 47.13 | Sell |
| 20-day EMA: | 50.2 | Sell |
| 50-day EMA: | 47.47 | Sell |
| 200-day EMA: | 38.44 | Sell |
Blackrock Enhanced Cap&Inc Fund, Earnings Growth & CII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Blackrock Enhanced Cap&Inc Fund, Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||